It-Torċa reports that a Malta-based pharmaceutical company is conducting clinical trials on a medicine to cure inflammatory diseases caused by the Covid-19 virus. Malta Enterprise is supporting the project with a $5 million fund.
Another story says that credit rating agency DBRS has confirmed Malta’s A (High) rating. The paper says that eight international companies in the last ten months have projected stable and positive outlooks for Malta’s economy.
Keep in the know with the latest edition of CorporateDispatchPro
